SAGE - Sage Therapeutic - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

SAGE is currently covered by 20 analysts with an average price target of $37.17. This is a potential upside of $21.54 (137.81%) from yesterday's end of day stock price of $15.63.

Sage Therapeutic's activity chart (see below) currently has 333 price targets and 296 ratings on display. The stock rating distribution of SAGE is 37.29% BUY and 62.71% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.77% with an average time for these price targets to be met of 165.21 days.

Highest price target for SAGE is $34, Lowest price target is $20, average price target is $37.17.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 26-Mar-2024. First documented stock forecast 12-Aug-2014.

Currently out of the existing stock ratings of SAGE, 22 are a BUY (37.29%), 37 are a HOLD (62.71%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

29

$12.4 (74.70%)

61

24 days ago

0/3 (0%)

$10.38 (55.75%)

Hold

26

$9.4 (56.63%)

26

1 months 8 days ago

17/31 (54.84%)

$4.82 (22.76%)

142

Hold

22

$5.4 (32.53%)

20

1 months 22 days ago

5/7 (71.43%)

$-0.55 (-2.44%)

118

Hold

28

$11.4 (68.67%)

27

2 months 4 days ago

8/12 (66.67%)

$2.59 (10.19%)

193

Buy

34

$17.4 (104.82%)

24

3 months ago

1/4 (25%)

$7.99 (30.72%)

61

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SAGE (Sage Therapeutic) average time for price targets to be met?

On average it took 165.21 days on average for the stock forecasts to be realized with a an average price target met ratio 51.77

Which analyst has the current highest performing score on SAGE (Sage Therapeutic) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on SAGE (Sage Therapeutic)?

John Newman works at CANACCORD and has 3 price targets and 3 ratings on SAGE

Which analyst is the currently most bullish on SAGE (Sage Therapeutic)?

Adam Walsh with highest potential upside - $220.6

Which analyst is the currently most reserved on SAGE (Sage Therapeutic)?

James Lee with lowest potential downside - -$1.86

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?